跳至主要内容
临床试验/NCT03379896
NCT03379896Unknown不适用

Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms

West China Hospital0 个研究点目标入组 60 人开始时间: 2018年1月4日最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
主要终点
28-day clinical outcome

研究概览

简要总结

Study on antigen-presenting function of gamma delta T cells in sepsis and its molecular mechanisms

详细描述

The latest definition of sepsis highlights the role of dysregulated host response to infection in organ dysfunction aggravation. Maintenance of immune homeostasis of septic patients through immunotherapy is the key breakthrough to improve success rate. Antigen-presenting cell (APC) is the bridge that connects the innate and adaptive immunity. Decrease of count and function of APC has been shown to be associated with worsened clinical outcomes in patients with sepsis. Gamma-delta T cells (γδ T cells) are the newly identified population of T lymphocytes. Recent studies have found that γδ T cells possess unique and powerful antigen-presenting function, making them the hot topic in infection and cancer research. Based on the results, the investigator plan to evaluate the antigen-presenting function changes of γδ T cells in septic status by analyzing the antigen-presenting related molecules on γδ T cells, antigen protein uptake ability, and their function on the proliferation and activation of CD8+ T lymphocytes. Furthermore, the investigator will explore the mechanism and signal pathways for the APC function changes of γδ T cells. Findings from this research could help explain the mechanism of sepsis induced immune dysfunction, enrich our understanding of the important role of γδ T cells, and build a good foundation for immunotherapy in sepsis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 year old;
  • a known or suspected infection based on clinical data at the time of admission and sepsis-induced dysfunction of at least one organ.

排除标准

  • autoimmune disease,
  • history of transplantation,
  • acute tuberculosis,
  • chronic hepatitis B or C infection,
  • HIV infection,
  • active malignancy, and
  • long-term use of cortical steroids.

结局指标

主要结局

28-day clinical outcome

时间窗: 28-day after ICU admission

death

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kang Yan

Yan Kang, Director of Department of Critical Care Medicine

West China Hospital

相似试验